Jennifer Jackson, Ph.D., has been appointed senior vice president of Regulatory Affairs at Cubist Pharmaceuticals. Dr. Jackson will oversee all regulatory affairs, providing oversight for all U.S. and international regulatory matters, including filings and interactions with regulatory authorities. Dr. Jackson will report to Steve Gilman, Ph.D., Cubist’s executive vice president of R&D and chief scientific officer. Dr. Jackson joins the company from Biogen Idec Hemophilia, where she was vice...